- Corporate Officers - F
- Foley Todd
Insider Trading History of Foley Todd
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Foley Todd since 2014.
This trader's CIK number is 1473930.
At the time of last reporting, Foley Todd was the Officer of Iteos Therapeutics, Inc.. (stock ticker symbol ITOS).
Also see all insider trading activities at Iteos Therapeutics, Inc..
Note that in the past
Foley Todd also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Eiger Biopharmaceuticals, Inc. (CLDN) by Foley Todd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | CLDN | 111,608 | $892,864 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Rhythm Pharmaceuticals, Inc. (RYTM) by Foley Todd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | RYTM | 0 | $0 | 1,000,000 | $25,100,000 | 0 | $0 |
| 2020 | RYTM | 0 | $0 | 484,239 | $10,030,906 | 0 | $0 |
| 2019 | RYTM | 0 | $0 | 681,396 | $15,460,183 | 0 | $0 |
| 2017 | RYTM | 100,000 | $1,700,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Entrada Therapeutics, Inc. (TRDA) by Foley Todd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | TRDA | 100,000 | $2,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Werewolf Therapeutics, Inc. (HOWL) by Foley Todd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | HOWL | 0 | $0 | 1,963 | $2,061 | 0 | $0 |
Yearly summary of insider trading at Repare Therapeutics Inc. (RPTX) by Foley Todd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | RPTX | 0 | $0 | 677,145 | $20,866,919 | 0 | $0 |
| 2020 | RPTX | 250,000 | $5,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Aratana Therapeutics, Inc. (PETX) by Foley Todd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | PETX | 0 | $0 | 12,539 | $250,153 | 0 | $0 |
Yearly summary of insider trading at Iteos Therapeutics, Inc. (ITOS) by Foley Todd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | ITOS | 0 | $0 | 630,191 | $5,079,339 | 0 | $0 |
Insider trading activities at 7 companies by Foley Todd:
1. Eiger Biopharmaceuticals, Inc. (CLDN)
2. Rhythm Pharmaceuticals, Inc. (RYTM)
3. Entrada Therapeutics, Inc. (TRDA)
4. Werewolf Therapeutics, Inc. (HOWL)
5. Repare Therapeutics Inc. (RPTX)
6. Aratana Therapeutics, Inc. (PETX)
7. Iteos Therapeutics, Inc. (ITOS)
Table 1. Insider trading of Eiger Biopharmaceuticals, Inc. (CLDN) by Foley Todd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-02-04 | CLDN | Buy | 111,608 | 8.00 | 892,864 |
Table 2. Insider trading of Rhythm Pharmaceuticals, Inc. (RYTM) by Foley Todd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-03-15 | RYTM | Sale | 1,000,000 | 25.10 | 25,100,000 |
| 2020-06-26 | RYTM | Sale | 300 | 25.04 | 7,512 |
| 2020-06-24 | RYTM | Sale | 97,388 | 25.34 | 2,467,811 |
| 2020-06-25 | RYTM | Sale | 17,947 | 25.41 | 456,033 |
| 2020-06-05 | RYTM | Sale | 1,896 | 20.00 | 37,920 |
| 2020-06-01 | RYTM | Sale | 10,535 | 20.08 | 211,542 |
| 2020-06-02 | RYTM | Sale | 15,578 | 20.23 | 315,142 |
| 2020-06-03 | RYTM | Sale | 18,245 | 20.27 | 369,826 |
| 2020-05-27 | RYTM | Sale | 10,148 | 20.13 | 204,279 |
| 2020-05-28 | RYTM | Sale | 19,152 | 20.19 | 386,678 |
| 2020-05-26 | RYTM | Sale | 44,421 | 20.47 | 909,297 |
| 2020-05-21 | RYTM | Sale | 25,594 | 20.25 | 518,278 |
| 2020-05-22 | RYTM | Sale | 26,906 | 20.13 | 541,617 |
| 2020-05-18 | RYTM | Sale | 21,349 | 20.00 | 426,980 |
| 2020-05-19 | RYTM | Sale | 2,633 | 20.00 | 52,660 |
| 2020-05-20 | RYTM | Sale | 10,527 | 20.01 | 210,645 |
| 2020-05-13 | RYTM | Sale | 1,837 | 20.04 | 36,813 |
| 2020-05-11 | RYTM | Sale | 22,155 | 20.34 | 450,632 |
| 2020-05-12 | RYTM | Sale | 24,342 | 20.23 | 492,438 |
| 2020-05-08 | RYTM | Sale | 6,633 | 20.05 | 132,991 |
| 2020-05-06 | RYTM | Sale | 1,626 | 20.00 | 32,520 |
| 2020-05-07 | RYTM | Sale | 200 | 20.01 | 4,002 |
| 2020-04-28 | RYTM | Sale | 15,826 | 20.07 | 317,627 |
| 2020-04-29 | RYTM | Sale | 20,397 | 20.12 | 410,387 |
| 2020-03-31 | RYTM | Sale | 19,108 | 15.16 | 289,677 |
| 2020-04-01 | RYTM | Sale | 15,462 | 15.10 | 233,476 |
| 2020-03-26 | RYTM | Sale | 2,300 | 15.04 | 34,592 |
| 2020-03-20 | RYTM | Sale | 1,100 | 15.00 | 16,500 |
| 2020-03-18 | RYTM | Sale | 12,781 | 15.14 | 193,504 |
| 2020-03-17 | RYTM | Sale | 9,653 | 15.12 | 145,953 |
| 2020-03-19 | RYTM | Sale | 8,200 | 15.07 | 123,574 |
| 2019-12-11 | RYTM | Sale | 13,600 | 25.14 | 341,904 |
| 2019-12-12 | RYTM | Sale | 3,762 | 25.01 | 94,087 |
| 2019-12-09 | RYTM | Sale | 22,195 | 25.04 | 555,762 |
| 2019-12-10 | RYTM | Sale | 41,839 | 25.36 | 1,061,037 |
| 2019-12-02 | RYTM | Sale | 25,366 | 22.03 | 558,812 |
| 2019-12-03 | RYTM | Sale | 16,777 | 22.33 | 374,630 |
| 2019-11-29 | RYTM | Sale | 18,359 | 22.67 | 416,198 |
| 2019-11-27 | RYTM | Sale | 34,960 | 22.91 | 800,933 |
| 2019-11-26 | RYTM | Sale | 74,225 | 23.31 | 1,730,184 |
| 2019-11-25 | RYTM | Sale | 121,343 | 23.19 | 2,813,944 |
| 2019-11-22 | RYTM | Sale | 102,682 | 21.91 | 2,249,762 |
| 2019-11-20 | RYTM | Sale | 141,365 | 22.02 | 3,112,857 |
| 2019-11-21 | RYTM | Sale | 64,923 | 20.80 | 1,350,073 |
| 2017-10-10 | RYTM | Buy | 100,000 | 17.00 | 1,700,000 |
Table 3. Insider trading of Entrada Therapeutics, Inc. (TRDA) by Foley Todd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-11-02 | TRDA | Buy | 100,000 | 20.00 | 2,000,000 |
Table 4. Insider trading of Werewolf Therapeutics, Inc. (HOWL) by Foley Todd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-03-27 | HOWL | Sale | 1,963 | 1.05 | 2,061 |
Table 5. Insider trading of Repare Therapeutics Inc. (RPTX) by Foley Todd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-07-12 | RPTX | Sale | 25,559 | 33.84 | 864,916 |
| 2021-07-09 | RPTX | Sale | 1,792 | 33.06 | 59,243 |
| 2021-06-21 | RPTX | Sale | 16,562 | 34.22 | 566,668 |
| 2021-06-22 | RPTX | Sale | 1,675 | 33.73 | 56,489 |
| 2021-06-23 | RPTX | Sale | 622 | 32.98 | 20,513 |
| 2021-06-18 | RPTX | Sale | 3,966 | 33.74 | 133,832 |
| 2021-06-17 | RPTX | Sale | 14,328 | 33.95 | 486,435 |
| 2021-06-14 | RPTX | Sale | 881 | 33.09 | 29,152 |
| 2021-06-16 | RPTX | Sale | 1,862 | 33.33 | 62,060 |
| 2021-06-08 | RPTX | Sale | 11,544 | 33.10 | 382,164 |
| 2021-06-09 | RPTX | Sale | 15,523 | 34.60 | 537,173 |
| 2021-06-03 | RPTX | Sale | 9,824 | 31.92 | 313,582 |
| 2021-06-04 | RPTX | Sale | 5,612 | 31.04 | 174,196 |
| 2021-06-07 | RPTX | Sale | 10,186 | 31.98 | 325,778 |
| 2021-05-27 | RPTX | Sale | 3,503 | 32.98 | 115,546 |
| 2021-05-26 | RPTX | Sale | 10,590 | 32.88 | 348,146 |
| 2021-05-25 | RPTX | Sale | 2,896 | 33.23 | 96,234 |
| 2021-05-21 | RPTX | Sale | 133,359 | 34.80 | 4,640,893 |
| 2021-05-24 | RPTX | Sale | 9,782 | 33.79 | 330,533 |
| 2021-05-18 | RPTX | Sale | 10,312 | 34.55 | 356,279 |
| 2021-05-19 | RPTX | Sale | 5,968 | 34.62 | 206,582 |
| 2021-05-20 | RPTX | Sale | 4,387 | 34.92 | 153,215 |
| 2021-03-12 | RPTX | Sale | 376,412 | 28.18 | 10,607,290 |
| 2020-06-23 | RPTX | Buy | 250,000 | 20.00 | 5,000,000 |
Table 6. Insider trading of Aratana Therapeutics, Inc. (PETX) by Foley Todd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-03-07 | PETX | Sale | 12,539 | 19.95 | 250,153 |
Table 7. Insider trading of Iteos Therapeutics, Inc. (ITOS) by Foley Todd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-05-13 | ITOS | Sale | 630,191 | 8.06 | 5,079,339 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Foley Todd
(Officer of Iteos Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.